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Rats have important advantages over mice as an
experimental system for physiological and pharma-
cological investigations. The lack of rat embryonic
stem (ES) cells has restricted the availability of
transgenic technologies to create genetic models in
this species. Here, we show that rat ES cells can be
efficiently derived, propagated, and genetically
manipulated in the presence of small molecules that
specifically inhibit GSK3, MEK, and FGF receptor
tyrosine kinases. These rat ES cells express pluripo-
tency markers and retain the capacity to differentiate
into derivatives of all three germ layers. Most impor-
tantly, they can produce high rates of chimerism
when reintroduced into early stage embryos and
can transmit through the germline. Establishment of
authentic rat ES cells will make possible sophisti-
cated genetic manipulation to create models for the
study of human diseases.
INTRODUCTION
Embryonic stem (ES) cells are derived from the inner cell mass
(ICM) of preimplantation blastocysts (Brook and Gardner,
1997). They can be maintained in culture indefinitely while
retaining the capacity to generate nearly any type of cell in the
body (Keller, 2005). The pluripotency of ES cells, combined
with the ease with which they can be manipulated genetically,
has provided a powerful means to elucidate gene function and
create diseasemodels via the generation of transgenic, chimeric,
and knock-out animals. Although ES cells have been routinely
derived frommice since 1981 (Evans andKaufman, 1981;Martin,
1981), authentic rat ES cells have never been established.
In general, rats are more relevant to humans, both physiolog-
ically and pharmacologically, than mice, providing an important
experimental model system for the study of human diseases(Jacob and Kwitek, 2001). For example, rats have been used
extensively in studies of hypertension (Rapp, 2000). Because
of the lack of rat ES cells, the generation of novel rat models
for studying specific aspects of human diseases largely depends
on selection for specific traits using existing rat strains. Although
strategies based on chemical mutagenesis using the supermuta-
gen N-ethyl-N-nitrosourea (ENU) or mutagenesis using the L1
retrotransposon have been developed to introduce random
mutations into rats (Ostertag et al., 2007; Smits et al., 2006),
germline-competent ES cells will be required to achieve robust,
facile, and precise genetic modification in this species.
Derivation and maintenance of the undifferentiated state of
mouse ES cells originally relied on cocultivation with feeder cells,
usually mitotically inactivated mouse embryonic fibroblasts
(MEFs), and the presence of serum. Later, it was shown that
leukemia inhibitory factor (LIF) is the key cytokine secreted by
feeders in supporting mouse ES cell self-renewal (Smith et al.,
1988; Williams et al., 1988). We recently demonstrated that bone
morphogenetic proteins (BMPs) can replace serum and act
together with LIF to maintain mouse ES cell self-renewal (Ying
et al., 2003). Several groups have attempted to derive ES cells
from rats under similar culture conditions developed for mouse
EScells; however, noauthentic rat EScell lineshave ever beenes-
tablished (Brenin et al., 1997; Buehr et al., 2003; Demers et al.,
2007; Fandrich et al., 2002; Ueda et al., 2008; Vassilieva et al.,
2000). Pluripotent EpiSCs (postimplantation epiblast-derived
stem cells) have been derived from rat embryos at 7.5 days
postcoitus (dpc) (Brons et al., 2007). However, EpiSCs do not
contribute to chimeras, seriously limiting their potential use.
Although rat and mouse take much the same course of
embryogenesis during the early stages of development, the early
embryos differ significantly in their differentiation potential in vitro
or in vivo when they are transplanted to an ectopic site. For
instance, the isolated mouse epiblast can no longer regenerate
parietal endoderm (Gardner, 1985), whereas the rat epiblast
predominantly differentiates into parietal endoderm cells in
culture (Nichols et al., 1998).Mouse egg cylinders form teratocar-
cinomas containing pluripotent embryonic carcinoma stem cells
after being implanted to ectopic sites (Solter et al., 1970; Stevens,Cell 135, 1299–1310, December 26, 2008 ª2008 Elsevier Inc. 1299
Figure 1. Rat ES Cells Derived and Maintained in 3i Conditions Express Pluripotency Markers
(A–C) Immunofluorescence staining for Oct4 in the outgrowths of DA rat blastocysts. E4.5 DA rat blastocysts were plated onto mitotically inactivated MEFs with
different culture medium: serum-free N2B27medium supplemented with 3i (A), N2B27medium only (B), or GMEM/10% FBS supplementedwith 10 ng/ml LIF (C).
Ten days after plating, the cultures were fixed and stained for Oct4. Scale bars represent 50 mm.
(D) Five days after plating, the outgrowths of DA rat blastocysts were disaggregated and replated onto new wells of 4-well plates. This phase contrast image
shows colonies of DA rat cells formed from a single outgrowth of blastocyst 4 days after the first disaggregation. The scale bar represents 50 mm.1300 Cell 135, 1299–1310, December 26, 2008 ª2008 Elsevier Inc.
1970). When the same procedure is carried out in the rat, only
a yolk sac carcinoma develops (Damjanov and Sell, 1977). These
differences may account for the failure of rat ES cell derivation
using conditions developed for mouse ES cell cultures. Although
the derivation of putative ES-like cells from other species has
been reported, only ES cells from mice have proven to be able
to efficiently contribute to chimeras and re-enter the germline,
which is the defining feature of true ES cells.
Extrinsic stimuli are thought to be necessary for the mainte-
nance of ES cell self-renewal. These stimuli may be provided
in an integrated manner by a cellular microenvironment or by
administration of cocktails of growth factors and cytokines
in vitro (Smith, 2001). Recently, we have made a striking
discovery in understanding mouse ES cell self-renewal (Ying
et al., 2008). We found that, contrary to dogma, mouse ES cell
self-renewal does not require activating signals from the LIF/
STAT3 and BMP/SMAD pathways, but only that ES cells be
shielded from inductive differentiation cues. On the basis of
these findings, we developed a culture medium containing three
inhibitors (3i): CHIR99021, PD184352, and SU5402. CHIR99021
is a well-characterized highly selective small molecule inhibitor
of glycogen synthase kinase 3 (GSK3) (Murray et al., 2004).
PD184352 and SU5402 are selective pharmacological inhibitors
of mitogen-activated protein kinase kinase (MEK) and fibroblast
growth factor (FGF) receptor tyrosine kinase, respectively
(Davies et al., 2000; Mohammadi et al., 1997). 3i can support effi-
cient derivation and maintenance of ES cells from different
strains of mice (Ying et al., 2008).
Here, we examine the effect of 3i on rat ES cell derivation to
determine whether this principle may be more broadly appli-
cable. We report for the first time that germline-competent rat
ES cells can also be established under 3i conditions.
RESULTS
3i Maintains the Expression of Oct4 in the Outgrowths
of Rat Blastocysts
Toexamine theeffect of 3i onsustaining theundifferentiated state
of rat pluripotent stem cells, we plated E4.5 Dark Agouti (DA) rat
blastocysts on MEFs in serum-free N2B27 medium with or
without 3i. The expression of the pluripotency marker Oct4 was
used as an assay for the presence of undifferentiated stem cells
in the primary outgrowths of rat blastocysts. In the presence of 3i,
Oct4 expressionwasmaintained in themajority of the outgrowths
(six out of nine) 10 days after plating (Figure 1A). In contrast, Oct4
was rapidly extinguished in all outgrowths of rat blastocysts
placed in N2B27 medium alone (zero out of eight) or in cultures
supplemented with LIF and serum (zero out of eight) conditions
permissive for mouse ES cell derivation (Figures 1B and 1C).
These data suggest that the uncommitted state in the primary
culture of rat blastocysts can also be sustained in 3i conditions,
as we have previously demonstrated in different strains of mice
(Ying et al., 2008).
3i Enables Efficient Derivation and Maintenance
of Rat ES Cells
To investigate whether 3i conditions can support the long-term
expansion of these rat blastocyst-derived undifferentiated cells,
we dissociated the outgrowths of DA rat blastocysts 5–7 days
after in 3i culture and replated them into wells of 4-well plates
under the same MEF/3i condition. Cells loosely attached to the
feeders and proliferated to formmorphologically undifferentiated
colonies (Figure 1D). These cells could be passaged repeatedly,
resulting in the establishment of stable cell lines (Figure 1E). We
established 11 cell lines from 32 plated DA blastocysts. These
established lines exhibited positive staining for alkaline phos-
phatase (AP) (Figure 1F) and expressed pluripotency markers
Oct4, Nanog, and Sox2 (Figures 1G–1J). The expression of
Oct4,Nanog, and Sox2was also verified by quantitative RT-PCR
(qRT-PCR) (Figure 1K). We routinely passage these cells every
3–4 days by dissociating them into single cells using trypsin
and replating onto wells preseeded with MEFs in 3i medium.
Cultures have been expanded for over 60 passages without
overt differentiation. We also found that these 3i rat ES cells,
like mouse ES cells, can be cryopreserved and recovered with
high efficiency by standard techniques. We tested the MEF/3i
condition for the derivation of ES cells from other strains of
rats. We have so far established six Sprague Dawley (SD) rat
ES cell lines from 20 blastocysts and five Fischer 344 (F344)
rat ES cell lines from 18 blastocysts.
To further confirm the identity of these cells, we examined
genome-wide gene expression using an Affymetrix GeneChip
Rat gene 1.0 ST array. These 3i rat cells express most of the plu-
ripotency-related genes at high levels (Table S1 available online).
We also performed hierarchical clustering analysis to compare
with the global gene expression patterns of rat embryonic fibro-
blasts (REFs) and mouse ES cells. This microarray analysis
shows that the gene expression profile of 3i rat cells resembles
mouse ES cells, and is distinct from that of REFs derived from
the same strain (Figure S1). All of these data together suggest
that these rat cells derived and maintained in 3i conditions
remain undifferentiated.
Rat ES Cells Have a Similar Expression Pattern of Cell
Surface Markers with Mouse, but Not Human ES Cells
Mouse and human ES cells have a distinct expression pattern of
cell surface markers that characterize the undifferentiated state
(Ginis et al., 2004). SSEA-1 is expressed in mouse ES cells but
(E) Phase contrast image of DA rat ES cells at passage 25. The scale bar represents 100 mm.
(F) Alkaline phosphatase staining of DA rat ES cells at passage 15. The scale bar represents 100 mm.
(G–I) Immunofluorescence staining for Oct4 (G), Nanog (H), and Sox2 (I) in DA rat ES cells after 15 passages in 3i conditions. Scale bars represent 50 mm.
(J) Western blot analysis of Oct4 expression in mouse and rat ES cells. Rat embryonic fibroblasts (REFs) were used as control.
(K) qRT-PCR analysis ofOct4,Nanog, and Sox2 expression in undifferentiated rat ES cells (rES) and REFs. Data were average of triplicate samples and represent
relative expression levels of indicated genes in rES and REFs.
(L) Expression of cell surface markers in mouse, rat, and human ES cells. Mouse ES cells were grown on gelatin in GMEM/10% FBSmedium supplemented with
LIF. Rat and human ES cells were maintained in MEF/3i and human ES cell culture conditions, respectively. The scale bar represents 50 mm.Cell 135, 1299–1310, December 26, 2008 ª2008 Elsevier Inc. 1301
is absent in human ES cells, whereas SSEA-4, TRA-1-60, and
TRA-1-81 are expressed in human ES cells but not in mouse
ES cells. To test whether rat ES cells are similar to mouse or
human ES cells in terms of cell surface marker expression, we
performed immunofluorescence staining for cell-surface anti-
gens SSEA-1, SSEA-4, and GCTM-2. Antibody GCTM-2 recog-
nizes a 200 kD keratan-sulfate proteoglycan that also bears the
TRA-1-60 antigen. We found that, similar to mouse ES cells, rat
ES cells expressed SSEA-1, but not SSEA-4 or GCTM-2
(Figure 1L).
Epigenetic Status of Rat ES Cells
ES cells have some epigenetic features that are distinguishable
from those of differentiated cells. One such feature is that a set
of promoters inEScells carry both trimethylated histoneH3 lysine
4 (H3K4me3) and H3K27me3 chromatin marks, which are asso-
ciated with gene activation and repression, respectively. These
so-called ‘‘bivalent domains’’ preferentially occur at transcription
start sites (TSSs) of key developmental genes in mouse ES cells
and function to silence these genes in ES cells while keeping
thempoised for lineage-specific activation and repression (Bern-
stein et al., 2006; Mikkelsen et al., 2007). To determine whether
Figure 2. Gene-Specific Histone and DNAMethylation
Profiles in Rat ES Cells and REFs
(A and B) The enrichment of H3K4me3 and H3k27me3 at the
TSSs of indicated genes was determined by ChIP qPCR in
DAc2 rat ES cells (A) and in REFs derived from E14.5 DA rat
embryos (B). Data are the average of triplicate qPCR results.
(C) Expression levels of indicated genes in rat ES cells (ESC)
and REFs were determined by qRT-PCR and were normalized
to Gapdh. Data are the average of triplicate samples.
(D) Bisulfite sequencing of DNA methylation of the Oct4 and
Nanog promoter regions in rat ES cells and REFs. Arrows
indicate the transcriptional start sites. Unmethylated and
methylated CpGs are shown with open and filled circles,
respectively.
rat ES cells also have this epigenetic feature, we
analyzed H3K4 and K27 trimethylation patterns of
ten selected genes that havebeen shown to contain
bivalent promoters inmouse ES cells and resolve to
monovalent state (H3K4me3 or H3K27me3) or
remain bivalent in MEFs (Mikkelsen et al., 2007).
Using chromatin immunoprecipitation (ChIP) and
qPCR, we found that six genes (Hoxa5, Irx3, Maf,
Hoxa9, Dlx1, and Pax9) were associated with biva-
lent promoters in rat ES cells, with four resolving
into either Lys4 or Lys27 trimethylation and two
remaining bivalent in REFs (Figures 2A and 2B).
Interestingly, the other four genes (Ramp2, Sall3,
Pou4f1, and Shh) were marked predominantly by
either Lys4 or Lys27 trimethylation in rat ES cells.
They remained the same modification in REFs
except one (Sall3) (Figures 2A and 2B). Using
qRT-PCR, we confirmed that genes marked by
H3K4me3 were expressed at high levels, whereas
those associated with H3k27me3 or bivalent
domains were barely detectable (Figure 2C). These results
suggest that some developmental genes are also marked by
a bivalent chromatin structure in rat ES cells, although diver-
gences of chromatin modification may exist between mouse
and rat ES cells. Generation of a genome-widemap of chromatin
states is needed to better understand epigenetic mechanisms of
gene regulation in rat ES cells.
Another important epigenetic feature of ES cells is that the
promoter regions of key pluripotency genes are unmethylated
(Meissner et al., 2008). We used bisulfite sequencing to examine
the DNA methylation status of the Oct4 and Nanog promoters in
rat ES cells and REFs. As shown in Figure 2D, both Oct4 and
Nanog promoter elements were fully unmethylated in rat ES
cells. However, the Oct4 promoter became hypermethylated in
REFs, and the Nanog promoter was also methylated, but to
a lesser extent.
Rat ES Cells Derived and Maintained in 3i Retain
the Capacity to Differentiate into Derivatives
of All Three Germ Layers
The classical method to induce ES cell differentiation is to allow
ES cells to grow in suspension and form three-dimensional1302 Cell 135, 1299–1310, December 26, 2008 ª2008 Elsevier Inc.
aggregates known as embryoid bodies (EBs) (Keller, 1995).
Within the EBs, ES cell differentiation proceeds on a schedule
similar to that in the embryo. We performed rat ES cell differen-
tiation using this EBmethod. Dissociated rat ES cells were plated
into noncoated dishes in the presence of serum. Instead of form-
ing EBs, the majority of rat ES cells died 2 days after plating. The
presence of 3i and feeders seems to be critical for the survival of
rat ES cells. Wemade twomodifications to the EB protocol: (1) 3i
was still added at half of the original concentration for the first
2 days of differentiation, and (2) GMEM/10% fetal bovine serum
(FBS)-conditioned medium collected from feeders was then
substituted for 3i to instigate EB formation. Under these condi-
tions, rat ES cells formed EBs (Figure 3A), although at much
lower efficiency compared with EB formation from mouse ES
cells.
We examined the expression of markers of pluripotency and
lineage commitment by RT-PCR during the process of EB differ-
entiation. Oct4 was significantly downregulated, whereas the
expression of markers for ectoderm (nestin), primitive endoderm
(Gata4 and Sox17), endoderm (AFP), and mesoderm (Flk1) was
induced in EBs (Figure 3B). We plated day 4 EBs onto matrigel-
coated dishes with either serum-free N2B27 medium (Figure 3C)
or serum-containing medium (Figures 3D and 3E). In N2B27
medium, a large proportion of cells differentiated into bIII-
tubulin-positive neurons (Figure 3C). We observed spontane-
ously beating areas in the cultures with serum (Movie S1). The
cells within the beating areas were positive for myosin staining
(Figure 3D). In theoutgrowthof EBs, largeproportions of cells dis-
played morphology typical of parietal endoderm cells and were
positive for Gata4 staining (Figure 3E). These results suggest
that the rat ES cells derived and maintained in 3i conditions are
pluripotent.
Rat ES Cells Derived in 3i Can Contribute to High Rates
of Chimerism and Transmit through the Germline
The defining feature of authentic ES cells is their capacity to
incorporate into the developing embryo and transmit through
the germline (Smith, 2001). We injected rat ES cells into blasto-
cysts to determine their potential to form germline chimeras. A
total of 43 F344 blastocysts were injected with DAc2 cells
(female, Figure 4A) and transferred to five pseudopregnant SD
rats. Seven pups were born, among which two male and three
female exhibited coat coloring indicative of the presence of DA
rat cells (Figure 4B and Table 1). DA rat ES cells have an agouti
(A/A) genetic background, whereas F344 and SD rats are both
albino (c/c). The albino coat color mutation is recessive to agouti;
thus, when only one allele is present, there should be no partial
expression. As a result, when a DA/F344 or DA/SD chimeric rat
is mated with a SD rat, the germline transmission of DA rat ES
cells can be easily identified by the presence of agouti coat color.
These DA/F344 chimeras were mated with SD rats, and all three
female chimeras have produced offspring with agouti coat color,
indicating the germline transmission of the DA rat ES cell
genome (Figure 4C). Microsatellite analysis further confirmed
Figure 3. In Vitro Differentiation of Rat ES Cells
(A) Phase contrast image of Day 4 EBs formed from DA rat ES cells. The scale bar represents 100 mm.
(B) RT-PCR analysis of gene expression in undifferentiated rat ES cells and EBs formed from rat ES cells.
(C) Day 4 rat ES cell-derived EBs were plated ontomatrigel-coated dishes and cultured in N2B27medium. Nine days after plating, cells were fixed and stained for
neuronal marker bIII-tubulin. The scale bar represents 50 mm.
(D) Fourteen days after replating of DA rat ES cell-derived EBs into GMEMmedium plus 10%FBS, spontaneously beating areas appeared. The cultures were then
fixed and stained for cardiomyocyte marker myosin.
(E) GATA4 immunofluorescence staining of differentiated cells derived from DA rat ES cells.Cell 135, 1299–1310, December 26, 2008 ª2008 Elsevier Inc. 1303
the presence of the DA rat ES cell genome in the resulting germ-
line offspring (Figure 4D and Table S2). One of the female germ-
line offspring has developed into a fertile adult and produced
a total of nine pups; six had an albino coat color, one was
agouti/berkshire, one was agouti/hooded, and one was black/
hooded (Figure 4E). The two agouti pups and two out of the six
albino pups carried both the agouti gene from DA genetic back-
ground and the nonagouti gene from the SD rat, whereas the
black/hooded and other four albino pups only had the nonagouti
gene, as expected (Figure 4F and Table S3) (Kuramoto et al.,
2001). Four more DA/F344 chimeras (three male, one female)
were generatedwith amale DA rat ES cell line DAc3 (Figure S2A).
Two male chimeras were infertile, whereas the female and the
other male chimeras produced all white pups. DAc3 cells had
an abnormal karyotype, which may account for their inability to
transmit through the germline (Table 1). We have also generated
one highly pigmented male DA/F344 chimera using karyotypi-
cally normal DAc8 cells (Table 1 and Figure S2B). This chimera
will be ready for mating in January, 2009.
The genetic backgrounds of the host embryos and the donor
ES cells are critical for germline transmission of the resulting
chimeras in mice (Schwartzberg et al., 1989). This is also likely
to be true in the rat. We have generated a total of 16 DA/SD
chimeras by injection of DA ES cells into SD blastocysts (Table
1 and Figure S2C). All the 16 DA/SD chimeras developed into
fertile adults and produced over 200 offspring. However, none
of these offspring, as judged by coat color, were products of
the transmission of the DA ES cell genome through the germline.
This result suggests that SD blastocysts may be not suitable as
a host embryo for DA ES cells. We also injected F344 rat ES cells
into a total of 29 DA blastocysts and transferred them to three
pseudopregnant SD rats. Three pups were born, and none of
them were chimeras (Table 1).
L Cell/2i Conditions Support Robust Propagation
and Genetic Manipulation of Rat ES Cells
Germline competent rat ES cells can be derived at relatively high
efficiency and can be maintained in long-term culture under the
MEF/3i condition, as shown above. However, we found that rat
ES cells adhere poorly and tend to form small clumps that easily
detach from feeders under this MEF/3i condition. Cell adhesion
is mainly mediated by the integrin receptor family. The majority
of integrins are expressed at a low level or are absent in rat ES
cells, as suggested from microarray analysis and qRT-PCR
results (Table S4 and Figure S3). Interestingly, integrin a7 and
integrin a6 are highly expressed in rat ES cells, suggesting that
Figure 4. Chimeras and Germline Offspring Produced from Rat ES Cells
(A) Cytogenetic analysis of DAc2 rat ES cells used for the production of germline chimeras.
(B) Five chimeras generated by injection of DAc2 rat ES cells into F344 rat blastocysts. The agouti coat color denotes the presence of introduced DA ES cells in
albino F344 hosts. Chimera numbers 1, 2, and 3 were female. The other two chimeras were male. F, female; M, male.
(C) All three DA/F344 female chimeras mated with SD males have produced pigmented offspring, indicating the transmission of the DA rat ES cell genome.
(D) DNA microsatellite analysis of DA rat ES cells, the three germline offspring, and their littermates. M, 100 bp DNA marker; 1, DAc2 rat ES cells; 2, DA rat; 3,
F344 rat; 4, SD rat; 5, 7, and 9, the three germline offspring; 6, 8, and 10, their littermates. The PCR primers for different microsatellite markers are listed in Table
S5, and the expected sizes of PCR products for different strains of rats are listed in Table S2.
(E) The first germline offspring (female) produced by chimera number 1 wasmatedwith an SDmale and had produced a litter of nine pupswith different coat color
patterns.
(F) Genotyping analysis of the above nine pups for the agouti gene. The agouti gene (A/A) is present in DA rats, but not in SD rats. Instead, SD rats have a nonagouti
gene (a/a) resulting from a loss-of-function mutation of the agouti gene (Kuramoto et al., 2001). The sizes of PCR products for agouti and nonagouti genes are
153 bp and 134 bp, respectively. M, 100bp DNAmarker; 1, the agouti/berkshire pup; 2, the agouti/hooded pup; 3, the black/hooded pup; 4–9, the six albino pups.1304 Cell 135, 1299–1310, December 26, 2008 ª2008 Elsevier Inc.
rat ES cells may attach well if the right extracellular matrix (ECM)
is provided. We have tested over 20 different types of cells as
feeder layers for the growth of rat ES cells. Although rat ES cells
did not adhere, or adhered poorly, to most of the feeders tested,
we found that L cells, which were derived from subcutaneous
connective tissues of adult male C3H/An mice, can efficiently
support adherent growth of undifferentiated rat ES cells. We also
found that the viability and growth of rat ES cells can be further
improved if we use a more potent MEK inhibitor PD0325901 to
replace both PD184352 and SU5402 (Ying et al., 2008). Rat ES
cells readily attached to mitotically inactivated L cells after
plating under the 2i (CHIR99021+PD0325901) condition and
did not detach even after forming large colonies (Figure 5A).
More importantly, rat ES cells maintained on this L cell/2i condi-
tion remained morphologically undifferentiated and expressed
pluripotency markers Oct4 and Sox2 after long-term culture
(Figure 5B).
We next used theCAG-eGFP-IRES-pac plasmid to assess the
feasibility of performing genetic manipulation in rat ES cells
Table 1. Rat ES Cell Karyotype and Chimera Production
Cell Line
DAc2
(42,XX)
DAc5
(42,XY)
DAc3
(43,XXY)
DAc8
(42,XY)
F1
(42,XY)
Karyotype
Background DA DA DA DA DA DA F344
Passage
Number
25 39 25 26 12 20 N/A
Diploid Cells,
Normal Count
19 22 18 0 20 16 N/A
Diploid Cells,
Cells with
Gain or Loss
2 0 3 20a 0 4 N/A
Polyploid:
Diploid
17:83 15:85 22:78 21:79 5:95 6:94 N/A
Blasotocyst Injection
Passage
Number
15 12 12 15 11 12
Host
Blastocyst
F344 SD SD F344 F344 DA
Foster Female SD SD SD SD SD SD
Number of
Blastocysts
Injected
43 104 9 28 24 29
Number Born 7 18 1 4 2 3
Number of
Chimeras
2M, 3F 8M, 7F 1F 3M, 1F 1M 0
Number of
Germline
Chimeras
3F 0 0 0 N/Ab 0
M, male; F, female.
aOf the 20 diploid cells examined, seven had an extra copy of the X chro-
mosome (43,XXY). Nine cells had a translocation involving a chromosome
12, and an X chromosome in addition to a normal X and a normal Y chro-
mosome [42, XY,-12,+Rb(12.X)]. Two cells showed random loss of the Y
chromosome, one other cell showed random loss of an X chromosome,
and another cell showed random loss of a chromosome 4.
b This chimera (Figure S2B) will be ready for mating in January, 2009.under L cell/2i conditions. The eGFP transgene is driven by
a robust CAG promoter. GFP-positive cells should also be resis-
tant to puromycin because of the IRES-pac cassette. Initially,
eGFP plasmids were transfected into rat ES cells via the conven-
tional electroporation method. Cell viability was low after trans-
fection, and very few colonies grew up 1 week after selection
in puromycin. We then tested the nucleofection method with
which high efficiency of gene transfer can be achieved (Hohen-
stein et al., 2008). About 40% of rat ES cells were GFP positive
a day after transfection by nucleofection in L cell/2i conditions.
We then added 0.4 mg/ml puromycin to select for stable transfec-
tants. Approximately 200GFP-positive colonies were formed out
of 10,000 rat ES cells plated 7 days after selection (Figure 5C).
GFP-positive colonies were picked and expanded to establish
stable GFP-positive rat ES cell lines (Figure 5D).
Elevated LIF/STAT3 Signaling Supports Rat
ES Cell Self-Renewal
Signal transducer and activator of transcription 3 (STAT3) is acti-
vated by tyrosine phosphorylation at a single site Tyr705, as well
as by serine phosphorylation at Ser727. Activation of STAT3 is
essential for mouse ES cell self-renewal mediated by signaling
through LIF/gp130 receptors (Niwa et al., 1998). Interestingly,
LIF/STAT3 signaling fails to maintain self-renewal of mouse
EpiScs and human ES cells (Brons et al., 2007; Daheron et al.,
2004; Humphrey et al., 2004; Tesar et al., 2007). To investigate
the potential role of LIF/STAT3 signaling in rat ES cells, we first
examinedwhether STAT3 is functional in rat ES cells. LIF strongly
induced phosphorylation of STAT3 at Tyr705 and Ser727 in
mouse and rat ES cells (Figure 6A). The expression of suppressor
of cytokine signaling 3 (Socs3), which is one of STAT3’s direct
target genes, was highly induced after stimulation with LIF
(Figure 6B). These data suggest that the LIF/STAT3 pathway is
functional in rat ES cells. We next examined whether LIF has
any beneficial effects on rat ES cells. Feeders produce LIF and
may mask any effects of exogenous addition of the factor, so
we plated rat ES cells onto laminin-coated dishes in N2B27
medium because rat ES cells do not attach to gelatin. All the cells
differentiated rapidly under this condition (Figure 6C). In the pres-
ence of LIF, approximately 10%–20% cells remained undifferen-
tiated after 7 days in culture (Figure 6D), suggesting that LIF has
a positive effect on rat ES cell self-renewal. However, the undif-
ferentiated cells could not be maintained beyond two passages.
Serum or BMP4 had no beneficial effect. In fact, we found that
addition of serum rapidly induced cell death and differentiation
even in 3i or 2i conditions. LIF alonewas also insufficient in retain-
ing the undifferentiated state of rat ES cells grown on feeders,
which may account for the previous failures in establishing rat
ES cells.
Feeder-dependent mouse ES cells from strains other than
129 undergo apoptosis and differentiation after the removal of
feeders even in the presence of LIF.We found that this phenotype
can be rescued simply by increasing STAT3 activation, suggest-
ing that STAT3’s function is dose-dependent (E.N.S. andQ.-L.Y.,
unpublished data). To examine the effect of elevated STAT3
activation in rat ES cells, we introduced a STAT3 transgene into
DAc2 cells. Overexpression of STAT3 in DAc2-STAT3 cells was
confirmed by Western blot (Figure 6E). The STAT3 transgeneCell 135, 1299–1310, December 26, 2008 ª2008 Elsevier Inc. 1305
was flanked by loxP sites. Treatment with Cre removed the
STAT3 transgene and simultaneously activated GFP (Figures
6E and 6F) (Ying et al., 2008). DAc2-STAT3 cells have beenmain-
tained in L cell/LIF conditions for 11 passages without overt
differentiation (Figure 6G), whereas the removal of LIF resulted
in rapid cell death and differentiation (data not shown). Cre rever-
tants (GFP positive) also died or differentiated after just one
passage, despite the presence of LIF (Figure 6H), which is similar
to wild-type DAc2 cells. Undifferentiated DAc2-STAT3 cells
could also be maintained in laminin/N2B27+LIF conditions for
up to five passages, after which they gradually died or differenti-
ated. These results suggest that rat ES cells, like mouse ES cells,
are also responsive to LIF/STAT3 signaling for self-renewal,
although factor(s) provided by feeders are still required for long-
term culture.
DISCUSSION
Our results demonstrate that the use of 3i enables us for the first
time to efficiently derive and maintain cells from rat blastocysts
with all the key features of ES cells: expression of pluripotency
markers Oct4, Nanog, and Sox2; long-term self-renewal; the
capacity to differentiate into derivatives of all three germ layers;
and most importantly, the ability to produce high rates of chime-
rism and to transmit through the germline. We have also devel-
oped methods that enable us to robustly propagate and geneti-
cally manipulate rat ES cells, paving the way for the application
Figure 5. Propagation and Genetic Manipu-
lation of Rat ESCells in LCells/2i Conditions
(A) DAc2 rat ES cells, 4 days after transfer from the
MEF/3i condition to the L cell/2i condition. The
scale bar represents 25 mm.
(B) Immunofluorescence staining for Oct4 and
Sox2 in DAc2 rat ES cells after 15 passages in
the L cell/2i condition. The scale bar represents
50 mm.
(C) One of the GFP-positive DAc2 rat ES cell colo-
nies formed after transfection with GFP plasmids
by nucleofection and selection with puromycin
in L cell/2i conditions. The scale bar represents
50 mm.
(D) DAc2-GFP rat ES cells maintained in L cell/2i
conditions for six passages. The scale bar repre-
sents 50 mm.
of gene targeting and related genome
engineering technologies in the rat.
In the past two decades, ES cells have
been routinely used to create loss of func-
tion (knockout) or gene replacement
(knockin) mutations by homologous
recombination in the mouse, providing
an invaluable tool for the functional char-
acterization of genes (Capecchi, 2005).
Now, the availability of true rat ES cells
provides an opportunity to adapt the
technology developed in the mouse to
the rat. However, we still need to over-
come several obstacles before rat ES cells can be used routinely
to produce transgenic and gene knockout rat models. We need
to optimize culture conditions so that we can efficiently perform
genetic manipulation in rat ES cells while their germline compe-
tency is retained. In addition, we need to find the optimal host,
donor, and recipient combination for efficient germline transmis-
sion of rat ES cells.
We found that it is technically challenging to genetically manip-
ulate rat ES cells in the MEF/3i condition. This is mainly because
rat ES cells are deficient in cell adhesion and are very sensitive to
drug selection under this condition. In contrast, L cell/2i condi-
tions allow us to robustly propagate and genetically manipulate
rat ES cells. We are currently investigating whether germline
competence of rat ES cells is retained after long-term culture in
L cell/2i conditions. ES cells are subjected to selection pressures
and are likely to acquire genetic and epigenetic changes that
favor self-renewal over differentiation. Chromosomal abnor-
mality is one the major causes for the loss of germline compe-
tence of mouse ES cells (Liu et al., 1997). This is likely also the
case in rat ES cells. We found that the karyotype of rat ES cells
is reasonably stable at early passage numbers, but chromosomal
abnormalities increase with higher passages (data not shown).
Developing optimal culture conditions for the maintenance of
chromosome stability in rat ES cells is clearly important for their
future broad applications. We routinely use trypsin to passage
rat EScells. Several studies indicate that theuseof trypsin selects
for aneuploid human ES cells in culture (Chan et al., 2008). It will1306 Cell 135, 1299–1310, December 26, 2008 ª2008 Elsevier Inc.
be of interest to find out whether nonenzymatic passaging
methods will improve the rat ES cell quality after long-term
expansion. CHIR99021 is the key component in the 3i or 2i formu-
lations. A recent report suggests that CHIR99021 can delay chro-
mosome alignment and induce chromosome instability in
cultured HeLa cells (Tighe et al., 2007). If the compound has the
same effect on rat ES cells, we then need to test other factors
that can replace CHIR99021, such asWnt3a (Willert et al., 2003).
Because of the advantage of the dominant agouti coat color,
we chose DA rat ES cells to perform most of the experiments
described in this paper. A relatively high efficiency of germline
Figure 6. Rat ES Cells Are Responsive to
LIF/STAT3 Signaling for Self-Renewal
(A) Analysis of STAT3 activation by western blot in
mouse and rat ES cells stimulated with 10 ng/ml
LIF for 30 min.
(B) qRT-PCR analysis of Socs3 induction by LIF
treatment in mouse 46C ES cells and rat ES cells.
Data represent mean ± SD of triplicate samples
from two independent experiments.
(C and D) Immunofluorescence staining for Oct4
and Sox2 in DAc2 rat ES cells 7 days after they
were cultured in laminin/N2B27 (C) or laminin/
N2B27+LIF (D) conditions. Scale bars represent
50 mm.
(E) Western blot analysis of STAT3 activation in
DAc2, DAc2-STAT3, and DAc2-STAT3-Cre rat
ES cells after treatment with 10 ng/ml LIF for
30 min.
(F) DAc2-STAT3 cells, 1 day after transient trans-
fection with Cre to remove the STAT3 transgene
and simultaneously activate GFP. The scale bar
represents 50 mm.
(G) Immunofluorescence staining for Oct4 and
Sox2 in DAc2-STAT3 cells after nine passages in
L cell/LIF conditions. The scale bar represents
50 mm.
(H) Immunofluorescence staining for Oct4 in
DAc2-STAT3-Cre cells at second passage in
L cell/LIF conditions. The presence of GFP
denotes the removal of the STAT3 transgene.
The scale bar represents 50 mm.
transmission was achieved by injection
of DA ES cells into F344 blastocysts and
the subsequent transfer of the embryos
to the recipient pseudopregnant SD
rats. However, we still do not know the
homologous recombination efficiency in
DA rat ES cells and whether they can still
efficiently transmit through the germline
after extensive genetic manipulation and
long-term culture. These properties are
essential if we are to exploit all the genetic
manipulation now only possible in mice.
We may need to test more different
strains of rat ES cell lines and different
strain blastocysts as host embryos
before we can identify one combination
that can yield desirable efficiency for both homologous recombi-
nation and germline transmission.
Germline-competent mouse and rat ES cells can both be
derived andmaintained in the same 3i condition. They also share
similar molecular and epigenetic signatures and are responsive
to LIF/STAT3 signaling for self-renewal. We hypothesize that
the fundamental mechanismunderlying self-renewal of authentic
ES cells might be conserved among different species. It will be of
interest to investigate whether ES cells from other mammals,
such as cows and pigs, can also be established using culture
formulations on the basis of the 3i principle.Cell 135, 1299–1310, December 26, 2008 ª2008 Elsevier Inc. 1307
EXPERIMENTAL PROCEDURES
Media, Feeders, Animals, and Primers
Serum-free N2B27 medium was prepared as described (Nichols and Ying,
2006). CHIR99021, PD184352, PD0325901, and SU5402 were provided by
Stem Cell Sciences plc. 3i medium was prepared by the addition of 3 mM
CHIR99021, 0.8 mM PD184352, and 2 mM SU5402 to N2B27 medium. In 2i
medium, 0.4 mM PD0325901 was used to replace PD184352 and SU5402.
g-irradiated MEFs were used as feeders and maintained in GMEM (Sigma)/
10% FBS (HyClone) medium. REFs were derived from E14.5 DA rat embryos.
Timed pregnant DA, F344, and SD rats were purchased from Harlan. Animal
experiments were performed according to the investigator’s protocols
approved by the USC Institutional Animal Care and Use Committee. All the
primer sequences are listed in Table S5.
Derivation, Propagation, and Gene Transfection of Rat ES Cells
Rat blastocysts were gently flushed out from the uteruses of E4.5 timed-
pregnant rats with N2B27 medium. After the removal of the zona with acid
tyrodes solution (Sigma), whole blastocysts were transferred into 4-well plates
and cultured on MEFs with 3i medium. After 5–7 days, the outgrowths of blas-
tocysts were disaggregated and replated in the same MEF/3i conditions.
Emerging ES cell colonies were then trypsinized and expanded. Established
rat ES cell lines were routinely maintained in MEF/3i conditions. Medium was
changed every other day, and cells were split with 0.05% trypsin every 3–
4 days. In L cell/2i conditions, feeders were prepared by mixing of g-irradiated
L cells (ATCC Number: CCL-1) with either MEFs or DR4 feeders at a ratio of
1–2:1 and plating onto gelatin coated dishes at a density of 53 104/cm2. DR4
feeders were prepared from E13.5 mouse embryos that have been engineered
to be resistant to hygromycin, puromycin, 6-thioguanine, and neomycin. For
nucleofection, 10 mg linearized pCAG-eGFP-IP or pPyFloxedMT-STAT3-IPgfp
plasmids were transfected into 2,000,000 rat ES cells with Mouse ES Cell Nu-
cleofector Kit (amaxa Inc.) according to the manufacturer’s instruction. The
pPyFloxedMTIPgfp vector has been described previously (Ying et al., 2008).
The full-length mouse STAT3 transgene was obtained from addgene. There
is only one amino acid difference betweenmouse and rat STAT3 proteins. After
nucleofection, cells were cultured in L cell/2i conditions (mixed with DR4
feeders), and 0.4 mg/ml puromycin was applied to select for stable transfec-
tants 2 days after transfection. Individual stably transfected colonies were
picked and expanded. For removal of the STAT3 transgene, DAc2-STAT3 cells
were transfected with pCAG-Cre-IP plasmids using Lipofectin LTX (Invitrogen)
and the resulting GFP-positive cells were separated by FACS sorting.
Rat Blastocyst Injection
Blastocyst injection was performed as described (Nagy et al., 2003) with some
modification. Blastocysts from E4.5 timed-pregnant rats were placed into
a droplet of M2 medium and incubated in M16 medium (Sigma) for 2–3 hr,
and the well-expanded blastocysts were used for microinjection. Eight to
twelve rat ES cells (passage numbers between 12 and 15) were injected into
each blastocyst and incubated at 37C for 1 hr in M16 medium to allow the
recovery of embryos. Eight to ten embryos were then transferred into the
uterine horn of each E3.5 pseudopregnant female SD rat. Chimeric rats were
identified by coat color. Germline transmission was tested by mating chimeras
with SD rats.
In Vitro Differentiation of Rat ES Cells
Differentiation of rat ES cells was induced by the formation of EBs. Rat ES cells
were plated into noncoated Petri dishes in REF-conditioned medium contain-
ing GMEM/10% FBS plus 1 mM glutamine. Cells grew in suspension and
formed EBs, which were then plated onto matrigel coated dishes in either
N2B27 or GMEM/10% FBS medium. The expression of markers for the three
germ layers was examined by RT-PCR or immunostaining.
Immunostaining and AP Staining
Immunostaining was performed via standard protocols. Primary antibodies
used include the following: Oct4 (C-10, Santa Cruz, 1:200), Sox2 (Y-17, Santa
Cruz, 1:200), SSEA-1 (480, Santa Cruz, 1:200), SSEA-4 (813-70, Santa Cruz,
1:200), GATA-4 (G-4, Santa Cruz, 1:200), Nanog (Abcam, 1:200), bIII-tubulin1308 Cell 135, 1299–1310, December 26, 2008 ª2008 Elsevier Inc.(Sigma, 1:200), and Myosin (MF-20, 1:5). GCTM-2 antibody was provided by
Martin Pera’s lab. Alexa Fluor fluorescent secondary antibodies (Invitrogen)
were used at 1:1000 dilution. Nuclei were visualized with DAPI staining. AP
staining was performed with an alkaline phosphatase kit (Sigma) according
to the manufacturer’s instructions.
RT-PCR and qRT-PCR
Total RNA was extracted with RNA Easy Mini Kit (QIAGEN). cDNA was synthe-
sized with 1 mg of total RNA using Cloned AMV First-Strand cDNA Synthesis
Kit. AMV and Oligo (dT) 20 primers were used in a 20 ml reaction according
to the manufacturer’s instructions. PCR reaction mixtures were prepared
with Taq DNA polymerase (Invitrogen) and 1/20 of the above reaction as
template. qRT-PCR was performed with Power SYBR Green PCR Master
Mix (Applied Biosystems) according to manufacturer’s instructions. Signals
were detected with an ABI7900HT Real-Time PCR System (Applied Biosys-
tems). The relative expression level was determine by the 2-DCT method and
normalized against GAPDH.
Western Blot
Western blotting was performed according to a standard protocol. For the
detection of phosphorylatedSTAT3, cellswere stimulatedwith 10ng/ml human
LIF (Sigma) for 30 min. The primary antibodies used include the following: anti-
STAT3 (BD, 1:2000), anti-phospho-STAT3 (Tyr705) (Cell signaling, 1:2000), and
anti-phospho-STAT3 (S727) (Santa Cruz, 1:2000).
Genotyping and Karyotyping
Genotyping of animals was carried out by PCR on tail DNA. Primer sequences
for microsatellite analysis were obtained from rat genome database website
(http://rgd.mcw.edu/). For karyotyping, rat ES cells were treated with colcemid
(Sigma) at a final concentration of 100 ng/ml for 2 hr before being harvested for
metaphase preparation by standard methods. The GTW banding method was
used for chromosome analysis as described (Hsieh, 1997).
Bisulfite Sequencing
Genomic DNA was extracted with a genomic DNA purification kit (QIAGEN).
DNA (500 ng) from each sample was treated with EZ DNA methylation kit
(ZYMO) to convert the unmethylated C to U. The promoter regions of Oct4
and Nanog were amplified by PCR and cloned into pCR-Blunt II-TOPO vector
(Invitrogen) and sequenced with T7 and Sp6 primers.
Chromatin Immunoprecipitation
ChIP assays of cultured rat ES cells and REFs were performed as described
previously (Jia et al., 2006). In brief, chromatin from 1 3 107 fixed cells was
sonicated to a size range of 200–1000 bp as analyzed on agarose gels. Solubli-
lized chromatin was subjected to immunoprecipitation with antibody against
H3K4me3 (Abcam #8580) or H3K27me3 (Upstate #07-449). DNA samples
from ChIP preparation were analyzed by qPCR with SYBR Green PCR Master
Mix. The relative enrichment of each site was determined by the 2-DCT method
and normalized against input DNA.
DNA Microarray Analysis
Total RNA was extracted form rat ES cells or REFs with Trizol (Invitrogen) and
purified by RNeasy Clean up column (QIAGEN). RNA was amplified, labeled,
and hybridized to the Rat Affymetrix GeneChip Gene 1.0 ST Array according
to standard Affymetrix protocols.
ACCESSION NUMBERS
Microarray data have been deposited in the Gene Expression Omnibus Data-
base with the accession number GSE13681.
SUPPLEMENTAL DATA
Supplemental Data include three figures, five tables, and one movie and
can be found with this article online at http://www.cell.com/supplemental/
S0092-8674(08)01567-5.
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